Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial.
Jose Garcia-ArumiFrancisco Gómez-UllaAmparo NaveaEnrique CerveraAlex FonollosaLluis AriasJavier AraizJuan DonateMarta Suárez de FigueroaLucia ManzanasJaume CrespíRoberto GallegoPublished in: Journal of ophthalmology (2018)
An aflibercept TAE regimen improves visual acuity in patients with MO secondary to CRVO over 12 months with good tolerability.